Author

E. Haddock

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 5 Organism:mouse· 4 Organism:non-human primate· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

G. Saturday· 4 shared A. Okumura· 3 shared F. Feldmann· 3 shared J. Lovaglio· 3 shared N. van Doremalen· 3 shared P. Hanley· 3 shared T. Lambe· 3 shared C. K. Yinda· 2 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

G. Saturday

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Infection- or vaccine mediated immunity reduces SARS-CoV-2 transmission, but increases competitiveness of Omicron in hamsters

J. R. Port, C. K. Yinda, J. C. Riopelle, Z. A. Weishampel, T. A. Saturday, V. A. Avanzato, J. E. Schukz, M. G. Holbrook, K. Barbian, R. Perry-Gottschalk, E. Haddock, C. Martens, C. I. Shaia, T. Lambe, S. C. Gilbert, , V. J. Munster

This study shows that vaccination and prior infection reduce SARS-CoV-2 transmission but increase Omicron competitiveness in hamsters compared to Delta.

bioRxiv · Jul 29, 2022 · PreprintMicrobiology

Severe acute respiratory disease in American mink (Neovison vison) experimentally infected with SARS-CoV-2

D. R. Adney, J. Lovaglio, J. E. Schulz, C. K. Yinda, V. A. Avanzato, E. Haddock, J. R. Port, M. Holbrook, P. W. Hanley, G. Saturday, D. Scott, J. R. Spengler, C. Tansey, C. Cossaboom, N. Wendling, , V. J. Munster

This study shows that SARS-CoV-2 infected mink develop severe respiratory disease with features similar to severe acute respiratory disease in humans.

bioRxiv · Jan 20, 2022 · PreprintMicrobiology

ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys

N. van Doremalen, V. Avanzato, F. Feldmann, J. Schulz, E. Haddock, A. Okumura, J. Lovaglio, P. Hanley, K. Cordova, G. Saturday, T. Lambe, S. C. Gilbert, V. Munster

ChAdOx1 NiV vaccination protects African green monkeys from lethal Nipah virus infection, preventing disease signs and viral replication.

bioRxiv · Jul 20, 2021Microbiology

Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2

K. Rosenke, M. Jarvis, F. Feldmann, B. Schwarz, A. Okumura, J. Lovaglio, G. Saturday, P. Hanley, K. Meade-White, B. Williamson, F. Hansen, L. Perez-Perez, S. Leventhal, T.-L. Tang-Huau, M. Nason, , H. Feldmann

This study shows hydroxychloroquine does not reduce SARS-CoV-2 replication or improve clinical outcomes in hamsters or macaques.

bioRxiv · Jun 10, 2020 · PreprintPharmacology & Toxicology

A single dose of ChAdOx1 MERS provides broad protective immunity against a variety of MERS-CoV strains

N. van Doremalen, E. Haddock, F. Feldmann, K. Meade-White, T. Bushmaker, R. Fischer, A. Okumura, P. Hanley, G. Saturday, N. Edwards, M. Clark, T. Lambe, S. Gilbert, V. Munster

A single dose of ChAdOx1 MERS vaccine protects rhesus macaques and mice against MERS-CoV infection and multiple strains.

bioRxiv · Apr 13, 2020 · PreprintMicrobiology